Literature DB >> 31582356

Nivolumab for previously treated squamous oesophageal carcinoma.

Elizabeth C Smyth1, Florian Lordick2.   

Abstract

Entities:  

Year:  2019        PMID： 31582356     DOI： 10.1016/S1470-2045(19)30621-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8+ T cell augmentation.

Authors:  Chuan-Kun Shan; Yi-Bo Du; Xiao-Tian Zhai; Yue-Xuan Wang; Yi Li; Jian-Hua Gong; Zhi-Juan Ge; Xiu-Jun Liu; Yong-Su Zhen
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-03       Impact factor: 3.333

2.  The Depletion of ABI3BP by MicroRNA-183 Promotes the Development of Esophageal Carcinoma.

Authors:  Hongfei Cai; Yang Li; Da Qin; Rui Wang; Ze Tang; Tianyu Lu; Youbin Cui
Journal:  Mediators Inflamm       Date:  2020-07-26       Impact factor: 4.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.